Unraveling molecular characteristics and functional exploration of panoptosis for prognosis stratification in lung adenocarcinoma: a tumor marker prognostic study

Briefly, PAN Score is a robust biomarker for the prediction of prognosis and therapy response in LUAD patients. The YWHAG-vasopressin-PANoptosis axis may become the potential therapeutic target for LUAD.